New triple therapy aims to shrink stomach tumors before surgery
NCT ID NCT06766578
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new approach for people with locally advanced stomach or gastroesophageal junction cancer. Before surgery, patients receive low-dose radiation, an immunotherapy drug (tirelizumab), and chemotherapy (SOX). The goal is to see if this combination can completely eliminate the tumor before surgery. About 32 adults will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shandong Provincial Hospital
RECRUITINGJinan, Shandong, 250021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Arterial chemo combo shows promise in stomach cancer trial
- New drug cocktail aims to fight Hard-to-Treat stomach cancers
- Immunotherapy duo aims to shrink stomach tumors before surgery
- Could blood pressure pills boost stomach cancer treatment?
- Custom-Made cancer vaccine shows promise in advanced tumors
- Heated chemotherapy after stomach cancer surgery: a new hope?